CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
批准号:
8127648
负责人:
DAVID R BRIGSTOCK
金额:
$30.4万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2013-08-31
关键词:
AcetaldehydeAcinar CellAcuteAcute DiseaseAddressAdhesionsAlcohol consumptionAlcoholic PancreatitisAlcoholsApoptoticAreaAtrophicAutomobile DrivingBindingBiochemicalBiologicalBiological ProcessBiologyCell Proliferation RegulationCell SurvivalCell physiologyCellsCellular biologyChemotaxisChicagoCholelithiasisChondrogenesisChronicCicatrixCollagenConnective TissueContractsDefectDepositionDermalDevelopmentDiseaseDoctor of MedicineDoctor of PhilosophyEndocrineEstersEventExhibitsExtracellular MatrixExtracellular Matrix ProteinsFailureFatty AcidsFibrillar CollagenFibroblastsFibronectinsFibrosisGermanyGlandGrowth Factor ReceptorsIn VitroIncidenceIntegrin alpha5beta1IntegrinsInvestigationKnockout MiceLeadLesionMediatingMediator of activation proteinMedicalMesenchymalModalityModelingMusNecrosisNew YorkOrganPancreasPancreatic DiseasesPancreatic InjuryPancreatitisPathogenesisPathway interactionsPatientsPeptide HydrolasesPlayProcessProductionProgressive DiseaseProliferatingPropertyPublic HealthRegulationRelapseResearch PersonnelRoleSeveritiesSignal TransductionSmooth Muscle Actin Staining MethodStimulation of Cell ProliferationSubcutaneous InjectionsTestingTherapeuticTissuesTransforming Growth Factor betaWorkWound Healingacute pancreatitisalcohol effectangiogenesisautocrinebasecell injurycell typechronic pancreatitisclinically relevantcombatconnective tissue growth factordesignexperiencefibrogenesisin vivomigrationnew therapeutic targetnoveloptimismoxidant stressparacrinepreventresponseresponse to injuryskeletalskillsstellate celltooltransdifferentiationwound
中文摘要
描述(由申请人提供):广泛的、长期的目标是确定结缔组织生长因子(CTGF)在促进胰腺纤维化中的作用,这是慢性胰腺炎的一个共同特征。CTGF通过调节细胞增殖、迁移、转分化和细胞外基质分子的产生,刺激重要的生物过程,如软骨形成、血管生成和基质形成。CTGF敲除小鼠表现出致死性血管生成和骨骼缺损,而皮下注射CTGF可引起皮肤纤维化。CTGF在许多纤维化病变中过表达,在驱动纤维化过程中作用于转化生长因子- β (tgf - β)的下游。在胰腺炎期间,CTGF在多种细胞类型中过表达,并通过自分泌和旁分泌途径调节胰腺中主要纤维化细胞类型胰腺星状细胞(PSCs)的功能。因此,CTGF有望成为预防或逆转胰腺纤维化策略的新治疗靶点。我们的假设是酒精刺激PSC中CTGF的产生,并且CTGF通过结合和激活一种新的CTGF受体整合素alpha5beta1 (a5b1),在PSC中驱动促纤维化和抗凋亡通路。验证这一假设的具体目的是:1。测定乙醇及其代谢物对PSC中CTGF生成的影响;这些研究将评估乙醇、乙醛或脂肪酸乙酯对CTGF产生的影响,氧化应激和tgf - β的参与,以及CTGF在自分泌调节PSC功能中的作用;和2。确定PSC对CTGF的响应及整合素a5b1的作用;这些研究将探讨整合素a5b1在PSC中的表达、调控和激活,将评估整合素a5b1在CTGF介导PSC促纤维化和抗凋亡信号传导中的作用,并将评估CTGF在急性胰腺炎小鼠体内促进纤维形成的作用。这些研究与公共卫生的相关性在于,它们将确定CTGF调节PSC功能和胰腺纤维化的机制,从而导致新的治疗方式。
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objectives are to determine the role played by connective tissue growth factor (CTGF) in promoting pancreatic fibrosis, which is a common feature of chronic pancreatitis. CTGF stimulates vital biological processes such as chondrogenesis, angiogenesis and matrigenesis via its regulation of cell proliferation, migration, transdifferentiation and production of extracellular matrix molecules. CTGF knockout mice exhibit lethal angiogenic and skeletal defects, while subcutaneous injection of CTGF causes dermal fibrosis. CTGF is over-expressed in many fibrotic lesions and acts downstream of transforming growth factor- beta (TGF-beta) in driving fibrosis. During pancreatitis, CTGF is over-expressed by several cell types and acts via autocrine and paracrine pathways to regulate the function of pancreatic stellate cells (PSCs), the principal fibrogenic cell type in the pancreas. CTGF thus holds promise as a new therapeutic target in strategies designed to prevent or reverse pancreatic fibrosis. Our hypothesis is that CTGF production in PSC is stimulated by alcohol and that CTGF drives pro-fibrogenic and anti-apoptotic pathways in PSC through its binding and activation of integrin alpha5beta1 (a5b1), a novel CTGF receptor. The Specific Aims to test this hypothesis are 1. To determine the effect of ethanol and its metabolites on the production of CTGF in PSC; these studies will assess the effect of ethanol, acetaldehyde or fatty acid ethyl esters on CTGF production, the involvement of oxidant stress and TGF-beta, and the role of CTGF in autocrine regulation of PSC function; and 2. To determine the responses of PSC to CTGF and the role of integrin a5b1; these studies will address the expression, regulation, and activation of integrin a5b1 in PSC, will assess the role of integrin a5b1 in mediating pro-fibrogenic and anti-apoptotic signaling in PSC by CTGF, and will assess the role of CTGF in promoting fibrogenesis in vivo when administered against a background of acute pancreatitis in mice. The relevance of these studies to public health is that they will identify the mechanisms by which CTGF regulates PSC function and pancreatic fibrosis, and will thus lead to new treatment modalities.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/labinvest.2010.82
发表时间:
2010-08
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/j.cytogfr.2012.07.001
发表时间:
2013-02
期刊:
CYTOKINE & GROWTH FACTOR REVIEWS
影响因子:
13
作者:
[Charrier, Alyssa, Brigstock, David R.]
通讯作者:
Brigstock, David R.
DOI:
10.1007/s12079-014-0220-3
发表时间:
2014-06-01
期刊:
JOURNAL OF CELL COMMUNICATION AND SIGNALING
影响因子:
4.1
作者:
[Charrier, Alyssa, Chen, Ruju, Brigstock, David R.]
通讯作者:
Brigstock, David R.
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:9886400
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:10582586
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:10362721
-
项目类别:
-
资助金额:$42.05万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Hepatocyte Exosomes for Therapy of Ethanol-Induced Liver Injury
-
批准号:9370178
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2017
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Exosome platforms for assessment and therapy of chronic liver disease
-
批准号:8968550
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2015
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8438505
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:9015720
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8812761
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8275273
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8625264
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:8135102
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7848614
-
项目类别:
-
资助金额:$6.19万
-
财政年份:2009
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7799672
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:8054761
-
项目类别:
-
资助金额:$30.83万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7672571
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7197190
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7406688
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7600551
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7263604
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7502235
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
海外基金